The pathogenesis of renal injury and treatment in light chain deposition disease | Journal of Translational Medicine | Full Text
Kappa free light chain reduction ratio per patient and treatment protocol. | Download Table
![PDF] Prevalence and clinical significance of abnormal serum kappa/lambda light chain ratio in patients with chronic kidney disease. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/1444d9fcd1aa06934208ca29e69340f3ca084cbe/2-Table1-1.png "PDF] Prevalence and clinical significance of abnormal serum kappa/lambda light chain ratio in patients with chronic kidney disease. | Semantic Scholar")
PDF] Prevalence and clinical significance of abnormal serum kappa/lambda light chain ratio in patients with chronic kidney disease. | Semantic Scholar
International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders | Leukemia
Polyclonal free light chains: promising new biomarkers in inflammatory | CBF
Serum free light chain assessment in monoclonal gammopathy and kidney disease | Nature Reviews Nephrology
The renal range of the κ/λ sFLC ratio: best strategy to evaluate multiple myeloma in patients with chronic kidney disease | BMC Nephrology | Full Text
JCM | Free Full-Text | The Role of Light Kappa and Lambda Chains in Heart Function Assessment in Patients with AL Amyloidosis
Discrepancy in serum free light chain analysis compared with serum... | Download Scientific Diagram
Comparison of 2 Serum-Free Light-Chain Assays in CKD Patients - Kidney International Reports
Curing Cast Nephropathy by Removing Not-so-light Chains? — NephJC
Measuring Serum Free Light Chains (FLC) Improves Diagnosis and Prognosis for Patients with Monclonal Gammopathies - Warde Medical Laboratory
Effectiveness of Haemodiafiltration with Heat Sterilized High-Flux Polyphenylene HF Dialyzer in Reducing Free Light Chains in Patients with Myeloma Cast Nephropathy | PLOS ONE
Time course of serum creatinine and free light chains lambda for... | Download Scientific Diagram
Article: Monoclonal gammopathy of renal significance (MGRS) histopathologic classification, diagnostic workup, and therapeutic options (full text) - September 2019 - NJM
Serum Free Light Chains and the Risk of ESRD and Death in CKD Article
Manni Mohyuddin on Twitter: "Well- Normally kappa FLC are produced more often than lambda.. BUT lambda more frequently forms dimers, which doubles their molecular weight and slows their renal clearance..." / Twitter
Quantitative Assessment of Serum and Urinary Polyclonal Free Light Chains in Patients with Chronic Kidney Disease | American Society of Nephrology
Quantitative Assessment of Serum and Urinary Polyclonal Free Light Chains in Patients with Chronic Kidney Disease | American Society of Nephrology
View Image
JCM | Free Full-Text | Free Light Chains, High Mobility Group Box 1, and Mortality in Hemodialysis Patients
Serum free light chain measurement aids the diagnosis of myeloma in patients with severe renal failure | BMC Nephrology | Full Text
Polyclonal free light chains: promising new biomarkers in inflammatory | CBF
